Company intelligence / Profile preview

Peitho Translational

Ownership: Private
Development stage: Preclinical

Overview

Peitho Translational appears to be a consultancy or service provider specializing in guiding projects from preclinical drug discovery through early human testing, with particular expertise in central nervous system (CNS) therapeutics. The company’s work focuses on translational research bridging preclinical and clinical phases, especially within neuropharmacology. No specific pipeline assets or clinical trial outcomes are publicly detailed.

Therapeutic areas: Neurology
Modalities: Small molecules
Industry: Consulting

Drug pipeline

1 asset

gebr32a

Pre-clinical

Indications: Spinal cord injury

Beyond the preview

Go deeper on Peitho Translational.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peitho Translational.

Explore the full profile